Drug Profile
Research programme: goserelin polymeric micelle - Samyang
Alternative Names: Goserelin PM; Goserelin SRLatest Information Update: 25 Nov 2021
Price :
$50
*
At a glance
- Originator Samyang Biopharmaceuticals Corporation; Samyang Group
- Developer Samyang Biopharmaceuticals Corporation
- Class Antineoplastics; Infertility therapies; Oligopeptides; Pituitary hormone releasing hormones
- Mechanism of Action Gonadotropin releasing hormone stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 03 Mar 2016 Discontinued for Cancer in South Korea (Parenteral)